20/20 Onsite

20/20 Onsite 20/20 Onsite delivers comprehensive eye exams to businesses via a state-of-art mobile vision center.

20/20 Onsite (also known as 2020 Onsite) is the only provider solely dedicated to point-of-need eye assessments for clinical trials, proven to meet screening timelines, improve retention rates, and fast-track trials. This is a great way for companies to offer a unique, low-cost benefit to employees.

Meet Dr. Vaishali Keswani, OD — an optometrist whose story begins far from the clinic. "I was born in Uganda and came to...
11/21/2025

Meet Dr. Vaishali Keswani, OD — an optometrist whose story begins far from the clinic.

"I was born in Uganda and came to Toronto, Canada in 1972 as a refugee. That experience taught me the value of resilience, hard work, and community. I witnessed my parents' struggle at an early age to find their footing while learning a new language, finding new careers and raising two children in an unfamiliar land. These values have shaped me in how I approach patient care and teamwork."

Her journey with 20/20 Onsite started with a simple LinkedIn message:

"My journey with 2020 On-site actually began on LinkedIn, when a recruiter reached out to me about an opportunity to work on clinical trials. He connected me with Dr. Gibson. After learning more about the mission and how you were transforming access to clinical research through mobile vision clinics, I knew it was a perfect fit."

What keeps her coming back?

"I think what I love most is the sense of purpose and teamwork. It is really remarkable."

When asked what mindset is needed for this work, she shares:

"One needs to be flexible, curious and have a positive patient-focused mindset to do this kind of work. Patients' availability can change at the drop of a hat, and we need to accommodate that with a positive demeanor. I have to say the best part is working with the team from the top down. Everyone is so approachable and positive. I have a great relationship with all the clinical managers. We always have a great time!

Dr. Keswani reminds us that being part of 20/20 Onsite's OD Network means bringing your whole story, your compassion, and your spirit of adventure to work that truly matters.

Are you an OD looking for:

- Flexible travel opportunities that fit around your life
- Meaningful work that brings care directly to patients and families
- A supportive, collaborative team environment from top to bottom
- The chance to connect with diverse patients and communities across the country

If so, join our OD Network.

📩 To learn more, set up a quick chat with Dr. Katherine Harkins, Director of Optometry, at kharkins@2020onsite.com

You don’t need to currently have a problem for one to exist.Today’s small scheduling bottleneck or delay could become to...
11/20/2025

You don’t need to currently have a problem for one to exist.

Today’s small scheduling bottleneck or delay could become tomorrow’s missed milestone.
This session will help your team identify the early signals of risk, and respond fast before timelines or data quality are at stake.

Dec 10 | 12PM ET
Hosted by Jessica McKenzie, VP, Life Sciences
Register now: https://hubs.ly/Q03TLQ4W0

Happening today at NEXUS East!🎤 12:15–12:55 PM ET Chris Benevides, Director, Account Management, Life Sciences at 20/20 ...
11/19/2025

Happening today at NEXUS East!

🎤 12:15–12:55 PM ET
Chris Benevides, Director, Account Management, Life Sciences at 20/20 Onsite, joins the panel: “The Future of Decentralized & Hybrid Trials: What’s on the Horizon?”

If your protocol includes ocular endpoints, come hear how we de-risk endpoint collection, keep timelines on track, and reduce site/patient burden with point-of-need ophthalmic assessments.

Got 15 minutes on-site? Let’s map coverage and rapid deployment for your study.

👉 DM Chris or us to schedule, or comment “NEXUS” and we’ll reach out.

Your data, your timelines, your reputation—protected. With 20/20 Onsite, sponsors and CROs get peace of mind knowing the...
11/17/2025

Your data, your timelines, your reputation—protected.
With 20/20 Onsite, sponsors and CROs get peace of mind knowing their ocular endpoints are in expert hands, from first patient in to last patient out.

Partner with the endpoint protection experts.

If enrollment is slowing, screen-fails are rising, or referral sites are backing up—you don’t have a “small issue.” You ...
11/14/2025

If enrollment is slowing, screen-fails are rising, or referral sites are backing up—you don’t have a “small issue.” You have a timeline risk.

Join Jessica McKenzie, VP of Life Sciences at 20/20 Onsite, for an actionable, high-impact session on preventing avoidable misses in trials with ocular endpoints.

You’ll learn how to spot early warning signals before they snowball, and how rapid point-of-need deployment can rescue your study.

🎯 Webinar: Yes, Your Study Is at Risk: Risk Mitigation Plans for Endpoints
🗓️ Date: December 10 at 12PM ET
🔗 Register here: https://hubs.ly/Q03TdW2v0

Heading to NEXUS East (Nov 18–19 | Hilton Parsippany, NJ)? Let’s meet.Chris Benevides, Director, Account Management, Lif...
11/14/2025

Heading to NEXUS East (Nov 18–19 | Hilton Parsippany, NJ)? Let’s meet.

Chris Benevides, Director, Account Management, Life Sciences from 20/20 Onsite will be there to discuss de-risking ocular endpoints to keep timelines on track and reduce site/patient burden.

🎤 Catch Chris on the panel:
“The Future of Decentralized & Hybrid Trials: What’s on the Horizon?”
Day 2, 12:15–12:55 PM ET

If your protocol includes ocular endpoints let’s connect for a 15-minute on-site chat about coverage and rapid deployment.

👉 DM Chris or us to schedule or comment “NEXUS” and we’ll reach out.

Worried about protocol pitfalls? Get a complimentary review from 20/20 Onsite. We help you enroll faster, retain patient...
11/13/2025

Worried about protocol pitfalls?
Get a complimentary review from 20/20 Onsite.
We help you enroll faster, retain patients, and deliver results—on time, every time.

Read Our Protocol Risk Guide Here https://hubs.ly/Q03N_VKM0

We’re hiring a Patient Coordinator at 20/20 Onsite!Part-time, 4–8 pm ET (1–5 pm PT / 3–7 pm CT / 2–6 pm MT), contract ro...
11/10/2025

We’re hiring a Patient Coordinator at 20/20 Onsite!

Part-time, 4–8 pm ET (1–5 pm PT / 3–7 pm CT / 2–6 pm MT), contract role for ~3–6 months.

If you’re an organized, people-first problem solver who loves turning busy days into smooth patient experiences, this role is for you. You’ll help coordinate schedules, welcome patients, and keep our mobile eye-care operations running seamlessly, so clinical research teams can focus on advancing new therapies.

You’ll thrive if you:
- Communicate clearly and kindly with patients & partners
- Juggle details without dropping the ball
- Stay calm, proactive, and resourceful when plans change

Ready to make a real impact on patient access and clinical research? Apply here: https://hubs.ly/Q03SjzMF0

Will we see you at Neuroscience 2025?We’ve supported 20+ CNS trials—10 in just the last 10 months—and we’re ready to tal...
11/10/2025

Will we see you at Neuroscience 2025?

We’ve supported 20+ CNS trials—10 in just the last 10 months—and we’re ready to talk about de-risking timelines and protecting ocular endpoints at the point of need. If your protocol touches ocular, let’s make your data bulletproof.

📍 San Diego | Nov 15–19 (SfN Neuroscience 2025)
👋 Attending: Katie Sigg, Account Executive, Life Sciences

👉 DM Katie or us to schedule or comment “SfN” and we’ll reach out.

NEW BLOG: GLP-1: Reducing Dropout During Ocular Safety MonitoringOur new blog reveals why long-term ocular monitoring is...
11/06/2025

NEW BLOG: GLP-1: Reducing Dropout During Ocular Safety Monitoring

Our new blog reveals why long-term ocular monitoring is losing participants and the proven retention strategies that work.

🎯 Risk-based engagement
🎯 Multi-site consistency
🎯 Point-of-need solutions
🎯 Regulatory-ready documentation

Read the full strategy: https://hubs.ly/Q03PTTp90

Here at   this week! 👋Our team—Jessica McKenzie (VP, Life Sciences) and Chris Benevides (Director, Account Management, L...
11/04/2025

Here at this week! 👋
Our team—Jessica McKenzie (VP, Life Sciences) and Chris Benevides (Director, Account Management, Life Sciences)—is on the ground in Boston meeting sponsors and CROs about keeping ocular endpoints on-track.

A few takeaways from sessions attended so far:

- Decentralization is now table stakes—most studies won’t be fully DCT, but hybrid designs that give patients choice are becoming the norm.

- Site + patient burden wins the agenda. Vendors must deliver tight, operationally mature models that plug in without adding lift.

As one SVP of Global Clinical Trials put it yesterday (Nov 3, 2025): “For most trials, there must be decentralized options for patients, let them choose their path.”

If your protocol includes ocular endpoints and you’re exploring hybrid options, meet with Jess or Chris to talk point-of-need solutions that protect ocular endpoints without slowing your study.

👉 Grab a time here to on their calendars: https://hubs.ly/Q03Rz4Lz0

“Every neuro sponsor we serve asks the same questions: Will our endpoints be protected, will our patients stay engaged, ...
11/03/2025

“Every neuro sponsor we serve asks the same questions: Will our endpoints be protected, will our patients stay engaged, and will we hit our dates? Our answer is operational: certified people, standardized workflows, validated equipment, and a delivery model that meets patients where they are. That’s how we keep trials moving.” — Ivan Quiroz, VP Clinic Operations.

That's why leading sponsors and CROs trust 20/20 Onsite to protect what matters most.

We've now supported over 20 CNS trials (including 10 within the last 10 months) with certified teams, validated equipment, and a patient-first workflow delivered directly to the point of need.

The results speak for themselves:
* 95+ patient NPS
* 100% screening timelines met
* 91% retention rate vs industry average of 70%

Whether you're running a single-site study or a multi-region program, we scale with you without sacrificing quality or speed.

Full announcement: https://hubs.ly/Q03RjJrs0

Address

Boston, MA
02110

Alerts

Be the first to know and let us send you an email when 20/20 Onsite posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to 20/20 Onsite:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category